[1] [1] MIN H Y, LEE H Y. Molecular targeted therapy for anticancer treatment[J]. Exp Mol Med, 2022, 54(10): 1670-1694. DOI:10.1038/s12276-022-00864-3.

[2] [2] WANG Y Q, LI J Y, XIA L J. Plant-derived natural products and combination therapy in liver cancer[J/OL]. Front Oncol, 2023, 13:1116532[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/36865794/. DOI:10.3389/fonc.2023.1116532.

[3] [3] WANG H X, XUAN M, HUANG C,et al. Advances in research on bioactivity, toxicity, metabolism, and pharmacokinetics of usnic acidin vitroandin vivo[J/OL]. Molecules, 2022, 27(21): 7469[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/36364296/. DOI:10.3390/molecules27217469.

[4] [4] SUN T X, LI M Y, ZHANG Z H,et al. Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD-L1 expression and enhancing T-lymphocyte tumor-killing activity[J]. Phytother Res, 2021, 35(7): 3916-3935. DOI:10.1002/ptr.7103.

[5] [5] DEERLI E, TORUN V, CANSARAN-DUMAN D. miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2[J/OL]. Biol Res,2020, 53(1): 19[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/32366289/. DOI:10.1186/s40659-020-00285-4.

[6] [6] WU W B, GOU H, DONG J Y,et al. Usnic acid inhibits proliferation and migration through ATM mediated DNA damage response in RKO colorectal cancer cell[J]. Curr Pharm Biotechnol, 2021, 22(8): 1129-1138. DOI:10.2174/1389201021666201002155955.

[7] [7] YURDACAN B, EGELI U, GUNEY ESKILER G,et al. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid[J]. J Pharm Pharmacol,2019, 71(7): 1119-1132. DOI:10.1111/jphp.13097.

[8] [8] GIMA M, HERMAN-ANTOSIEWICZ A. Multifaceted properties of usnic acid in disrupting cancer hallmarks[J/OL]. Biomedicines,2024, 12(10): 2199[2025-05-16]. https://pubmed.ncbi.nlm.nih.gov/39457512/. DOI:10.3390/biomedicines12102199.

[9] [9] SUN Y, LIU Y, MA X L,et al. The influence of cell cycle regulation on chemotherapy[J/OL]. Int J Mol Sci, 2021, 22(13): 6923[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/34203270/. DOI:10.3390/ijms22136923.

[10] [10] KUMARI M, KAMAT S, JAYABASKARAN C. Usnic acid induced changes in biomolecules and their association with apoptosis in squamous carcinoma (A-431) cells: a flow cytometry, FTIR and DLS spectroscopic study[J/OL]. Spectrochim Acta A Mol Biomol Spectrosc,2022, 274: 121098[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/35257985/. DOI:10.1016/j.saa.2022.121098.

[11] [11] SINGH N, NAMBIAR D, KALE R K,et al. Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells[J]. Nutr Cancer, 2013, 65(Suppl 1): 36-43. DOI:10.1080/01635581.2013.785007.

[12] [12] YURDACAN B, EGELI U, GUNEY ESKILER G,et al. The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma[J]. Hum Exp Toxicol, 2019, 38(2): 201-215. DOI:10.1177/0960327118792052.

[13] [13] CHEN S, ZHANG Z H, QING T,et al. Activation of the Nrf2 signaling pathway in usnic acid-induced toxicity in HepG2 cells[J]. Arch Toxicol, 2017, 91(3): 1293-1307. DOI:10.1007/s00204-016-1775-y.

[14] [14] KOFLER L, GRUNDMANN L, GERHALTER M,et al. The novel ribosome biogenesis inhibitor usnic acid blocks nucleolar pre-60S maturation[J/OL]. Nat Commun, 2024, 15(1): 7511[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/39209816/. DOI:10.1038/s41467-024-51754-3.

[15] [15] CARNEIRO B A, EL-DEIRY W S. Targeting apoptosis in cancer therapy[J]. Nat Rev Clin Oncol, 2020, 17(7): 395-417. DOI:10.1038/s41571-020-0341-y.

[16] [16] KUMAR K, MISHRA J P N, SINGH R P. Usnic acid induces apoptosis in human gastric cancer cells through ROS generation and DNA damage and causes up-regulation of DNA-PKcs and -H2A. X phosphorylation[J/OL]. Chem Biol Interact, 2020, 315:108898[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/31715134/. DOI:10.1016/j.cbi.2019.108898.

[19] [19] BYK B P, CANSARAN DUMAN D, DUMAN T. BRAF inhibitor candidate molecule usnic acid might use both intrinsic and extrinsic pathways of apoptosis[J]. Turk J Med Sci, 2024, 54(5):1116-1126. DOI:10.55730/1300-0144.5890.

[20] [20] LI X H, HE S K, MA B Y. Autophagy and autophagy-related proteins in cancer[J/OL]. Mol Cancer, 2020, 19(1): 12[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/31969156/. DOI:10.1186/s12943-020-1138-4.

[21] [21] GENG X G, ZHANG X, ZHOU B,et al. Usnic acid induces cycle arrest, apoptosis, and autophagy in gastric cancer cellsin vitroandin vivo[J]. Med Sci Monit, 2018, 24: 556-566. DOI:10.12659/msm.908568.

[22] [22] LIU S Z, YAO S J, YANG H,et al. Autophagy: regulator of cell death[J/OL]. Cell Death Dis, 2023, 14(10): 648[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/37794028/. DOI:10.1038/s41419-023-06154-8.

[23] [23] CHEN S, DOBROVOLSKY V N, LIU F,et al. The role of autophagy in usnic acid-induced toxicity in hepatic cells[J]. Toxicol Sci, 2014, 142(1): 33-44. DOI:10.1093/toxsci/kfu154.

[24] [24] KUMARI M, KAMAT S, SINGH S K,et al. Inhibition of autophagy increases cell death in HeLa cells through usnic acid isolated from lichens[J/OL]. Plants, 2023, 12(3): 519[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/36771602/. DOI:10.3390/plants12030519.

[25] [25] LIU X R, ZHANG J, YI T,et al. Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies[J/OL]. Biomark Res, 2025, 13(1): 62[2025-05-16]. https://pubmed.ncbi.nlm.nih.gov/40251641/. DOI:10.1186/s40364-025-00779-x.

[27] [27] LIAGHAT M, FERDOUSMAKAN S, MORTAZAVI S H,et al. The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemoresistance, metastasis, and recurrence in solid tumors[J/OL]. Cell Commun Signal, 2024, 22(1): 575[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/39623377/. DOI:10.1186/s12964-024-01957-4.

[28] [28] MURALI A, RAJALINGAM K. Small Rho GTPases in the control of cell shape and mobility[J]. Cell Mol Life Sci, 2014, 71(9): 1703-1721. DOI:10.1007/s00018-013-1519-6.

[29] [29] YANG Y, NGUYEN T T, JEONG M H,et al. Inhibitory activity of (+)-usnic acid against non-small cell lung cancer cell motility[J/OL]. PLoS One, 2016, 11(1): e0146575[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/26751081/. DOI:10.1371/journal.pone.0146575.

[31] [31] PETROV K, BAKOROV M, DEMIKOV Z,et al. Usnic acid isolated fromUsnea antarctica(Du Rietz) reducedin vitroangiogenesis in VEGF- and bFGF-stimulated HUVECs and ex ovo in quail chorioallantoic membrane (CAM) assay[J/OL]. Life, 2022, 12(9):1444[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/36143480/. DOI:10.3390/life12091444.

[32] [32] SONG Y J, DAI F J, ZHAI D,et al. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways[J]. Angiogenesis, 2012, 15(3): 421-432. DOI:10.1007/s10456-012-9270-4.

[34] [34] XUE D F, ZHOU X M, QIU J X. Emerging role of NRF2 in ROS-mediated tumor chemoresistance[J/OL]. Biomed Pharmacother,2020, 131: 110676[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/32858502/. DOI:10.1016/j.biopha.2020.110676.

[35] [35] QI W C, LU C P, HUANG H L,et al. (+)-usnic acid induces ROS-dependent apoptosisviainhibition of mitochondria respiratory chain complexes and Nrf2 expression in lung squamous cell carcinoma[J/OL]. Int J Mol Sci, 2020, 21(3): 876[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/32013250/. DOI:10.3390/ijms21030876.

[36] [36] WU D J, LI M, HONG Y N,et al. Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia[J/OL]. J Adv Res, 2024:S2090-1232(24)00436-3[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/39384125/. DOI:10.1016/j.jare.2024.10.003.

[37] [37] SU Z Q, LIU Y H, GUO H Z,et al. Effect-enhancing and toxicity-reducing activity of usnic acid in ascitic tumor-bearing mice treated with bleomycin[J]. Int Immunopharmacol, 2017, 46: 146-155. DOI:10.1016/j.intimp.2017.03.004.

[38] [38] GUNEY ESKILER G, ERYILMAZ I E, YURDACAN B,et al. Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor-positive breast and prostate cancer cells[J/OL]. J Biochem Mol Toxicol, 2019, 33(8): e22338[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/30980508/. DOI:10.1002/jbt.22338.

[39] [39] INGLFSDTTIR K. Usnic acid[J]. Phytochemistry, 2002, 61(7):729-736. DOI:10.1016/S0031-9422(02)00383-7.

[40] [40] ZUGIC A, TADIC V, SAVIC S. Nano- and microcarriers as drug delivery systems for usnic acid: review of literature[J/OL]. Pharmaceutics, 2020, 12(2): 156[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/32075296/. DOI:10.3390/pharmaceutics12020156.

[41] [41] ZHENG P, DING B B, ZHU G Q,et al. Usnea acid-incorporated Ca2+/Mn2+ ions reservoirs for elevated ion-interference therapy through synergetic biocatalysis and osmolarity imbalance[J/OL]. Small, 2023, 19(29): e2300370[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/37029698/. DOI:10.1002/smll.202300370.

[42] [42] NIE W Z, SHEN Q K, QUAN Z S,et al. Bioactivities and structure-activity relationships of usnic acid derivatives: a review[J]. Mini Rev Med Chem, 2024, 24(14): 1368-1384. DOI:10.2174/0113895575277085231123165546.

[43] [43] KORNIENKO T E, CHEPANOVA A A, ZAKHARENKO A L,et al. Enhancement of the antitumor and antimetastatic effect of topotecan and normalization of blood counts in mice with lewis carcinoma by Tdp1 inhibitors-new usnic acid derivatives[J/OL]. Int J Mol Sci, 2024,25(2): 1210[2024-11-27]. https://pubmed.ncbi.nlm.nih.gov/38279210/. DOI:10.3390/ijms25021210.

[44] [44] DENG D P, WANG M M, SU Y,et al. Iridium(III)-based PD-L1 agonist regulates p62 and ATF3 for enhanced cancer immunotherapy[J]. J Med Chem, 2024, 67(8): 6810-6821. DOI:10.1021/acs.jmedchem.4c00404.